CRIS Current Research Information System

SANTUCCI, MARIA ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.078
EU - Europa 2.221
AS - Asia 2.199
AF - Africa 158
SA - Sud America 102
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.763
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.047
SG - Singapore 708
CN - Cina 642
GB - Regno Unito 604
VN - Vietnam 470
DE - Germania 313
SE - Svezia 290
IT - Italia 215
UA - Ucraina 193
RU - Federazione Russa 133
HK - Hong Kong 128
IN - India 108
FR - Francia 99
IE - Irlanda 91
NL - Olanda 83
BR - Brasile 73
TG - Togo 54
ZA - Sudafrica 48
EE - Estonia 42
JP - Giappone 40
CH - Svizzera 31
FI - Finlandia 30
KR - Corea 27
JO - Giordania 24
BG - Bulgaria 20
SC - Seychelles 19
CA - Canada 17
BE - Belgio 16
CI - Costa d'Avorio 16
NG - Nigeria 15
IR - Iran 13
GR - Grecia 12
AR - Argentina 11
ID - Indonesia 11
MX - Messico 11
PL - Polonia 9
CZ - Repubblica Ceca 8
RO - Romania 7
HR - Croazia 6
LT - Lituania 6
EC - Ecuador 5
ES - Italia 5
UZ - Uzbekistan 5
CL - Cile 4
IQ - Iraq 4
AU - Australia 3
BD - Bangladesh 3
PE - Perù 3
TR - Turchia 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
CO - Colombia 2
IL - Israele 2
KH - Cambogia 2
LB - Libano 2
MA - Marocco 2
PT - Portogallo 2
PY - Paraguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BO - Bolivia 1
CU - Cuba 1
EG - Egitto 1
GE - Georgia 1
GI - Gibilterra 1
GM - Gambi 1
HU - Ungheria 1
JM - Giamaica 1
KW - Kuwait 1
MD - Moldavia 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
VE - Venezuela 1
ZM - Zambia 1
Totale 7.763
Salva come PNG Salva come JPEG
Città #
Southend 514
Singapore 493
Ashburn 339
Chandler 317
Fairfield 315
Wilmington 173
Seattle 164
Dong Ket 160
Woodbridge 152
Houston 140
Jacksonville 137
Hong Kong 127
Ann Arbor 126
Princeton 111
Cambridge 107
Beijing 105
Dublin 90
Hefei 86
Boardman 71
Santa Clara 66
Nanjing 60
Lomé 54
Westminster 53
Padova 52
New York 42
Berlin 41
Tokyo 39
Los Angeles 37
Hanoi 34
Ho Chi Minh City 34
Bologna 29
Helsinki 29
Bern 28
Frankfurt am Main 26
Jinan 26
Seoul 26
Amman 24
Buffalo 24
Shenyang 24
Milan 21
Changsha 20
Medford 20
Mülheim 20
Sofia 20
Falkenstein 19
Falls Church 19
Hebei 19
San Diego 19
Saint Petersburg 18
Abidjan 16
Brussels 16
Abeokuta 15
Nanchang 15
Redmond 15
Verona 15
Tianjin 14
Taizhou 13
Des Moines 11
Hangzhou 11
Phoenix 11
Bengaluru 10
Guangzhou 10
Redondo Beach 10
Turin 10
London 9
Mahé 9
Zhengzhou 9
Dearborn 8
Jakarta 8
Kuban 8
Norwalk 8
Shanghai 8
Toronto 8
Xi'an 8
Bühl 7
Jiaxing 7
Munich 7
Ningbo 7
Rome 7
São Paulo 7
Bremen 6
Dallas 6
Florence 6
Harbin 6
Portsmouth 6
Washington 6
Andover 5
Düsseldorf 5
Kunming 5
Lanzhou 5
Nuremberg 5
Stockholm 5
Brooklyn 4
Montreal 4
Qingdao 4
Rio de Janeiro 4
San Jose 4
Shenzhen 4
Warsaw 4
Zanjan 4
Totale 5.085
Salva come PNG Salva come JPEG
Nome #
A calpain-cleaved fragment of β-catenin promotes BCRABL1+ cell survival evoked by autophagy induction in response to imatinib 254
9-Hydroxystearic acid upregulates p21WAF1 in HT29 cancer cells. 248
14-3-3 Binding and Sumoylation Concur to the Down-Modulation of β-catenin Antagonist chibby 1 in Chronic Myeloid Leukemia 242
BCR-ABL1-associated reduction of beta catenin antagonist Chibby1 in chronic myeloid leukemia. 211
NEW STRATEGIES IN THE TREATMENT OF CHRONIC MYELOID LEUKEMIA. COMBINED USE OF SRC AND TYROSINE KINASE INHIBITORS CIRCUMVENTS THE DEVELOPMENT OF DRUG-RESISTANCE 207
Chibby 1: A new component of β-catenin-signaling in chronic myeloid leukemia 202
Chibby drives β catenin cytoplasmic accumulation leading to activation of the unfolded protein response in BCR-ABL1+ cells 193
Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors 192
14-3-3 ligand prevents nuclear import of c-ABL protein in chronic myeloid leukemia 185
Acetylation of FOXO3a transcription factor in response to imatinib of chronic myeloid leukemia 183
CHK2 drives late G1/early S phase arrest of clonal myeloid progenitors expressing the p210 BCR-ABL tyrosine kinase in response to STI571 174
Endoplasmic reticulum stress initiates apoptotic death induced by STI571 inhibition of p210 bcr-abl tyrosine kinase. 169
Apoptotic death of Bcr-Abl-expressing myeloid progenitors in response to the m-Tor inhibitor RAD001 (Everolimus) is promoted by the nuclear import of c-Abl 169
P210 Bcr-abl tyrosine kinase interaction with histone deacetylase 1 modifies histone H4 acetylation and chromatin structure of chronic myeloid leukaemia haematopoietic progenitors 168
9-HSA INDUCES APOPTOSIS AND INCREASES SENSITIVITY TO IMATINIB IN IMATINIB RESISTANT COLON CANCER CELLS 167
9-HSA INDUCES APOPTOSIS AND INCREASES SENSITIVITY TO IMATINIB IN IMATINIB RESISTANT COLON CANCER CELLS 161
C6-Unsubstituted Pyrazolo[3,4-d]pyrimidines Are Dual Src/Abl Inhibitors Effective against Imatinib Mesylate Resistant Chronic Myeloid Leukemia Cell Lines. 159
Gadd45a transcriptional induction elicited by the Aurora kinase inhibitor MK-0457 in Bcr-Abl-expressing cells is driven by Oct-1 transcription factor 153
Cytoplasmatic compartmentalization by Bcr-Abl promotes TET2 loss-of-function in chronic myeloid leukemia 152
HDAC1 (histone deacetylase1) involvement in Chronic Myeloid Leukemia 148
Persistent Cdk2 inactivation drives growth arrest of BCR-ABL-expressing cells in response to dual inhibitor of SRC and ABL kinases SKI606 148
FOXM1 Transcription Factor: A New Component of Chronic Myeloid Leukemia Stem Cell Proliferation Advantage 148
HIF 1 Alpha: A Suitable Target for Multiple Myeloma 148
Histone H3 covalent modifications driving response of BCR-ABL1+ cells sensitive and resistant to imatinib to Aurora kinase inhibitor MK-0457 144
The p210BCR-ABL tyrosine kinase of chronic myeloid leukemia causes resistance to radio-induced apoptotic death by inhibiting the proapoptotic BAX gene 144
Discovery and SAR of 1,3,4-thiadiazole derivatives as potent Abl tyrosine kinase inhibitors and cytodifferentiating agents. 141
Modulation of apoptotic signalling by 9-hydroxystearic acid in osteosarcoma cells 141
Tyrosine kinase inhibotr STI571 (Imatinib) cooperates with wild type p53 on k562 cell line to enhance its pro-apoptotic effets 140
Zinc-finger transcription factor slug contributes to the survival advantage of chronic myeloid leukemia cells. 139
P53 and beta catenin cross-talk in the medulloblastoma cell line radiosensitivity 137
HIF-1a INHIBITION PROMOTES CELL CYCLE ARREST IN MULTIPLE MYELOMA 137
Ponatinib treatment in chronic myeloid leukemia cell lines targets aurora kinase A/FOXM1 axis 137
IPO-trimethylation of histone H3-lysine9 associated with P210 BCR-ABL tyrosine kinase of chronic myeloid leukaemia 132
FOXM1 Transcription Factor Is a Component of Beta Catenin Signaling in Hematopoietic Progenitors of Chronic Myeloid Leukemia 131
GENOMIC UNBALANCES ASSOCIATED WITH THE RESISTANCE TO IONIZING RADIATIONS OF A HUMAN OSTEOSARCOMA CELL LINE (SAOS) DETECTED BY COMPARATIVE GENOMIC HYBRIDIZATION (CGH-BASED TECHNIQUE) 130
mTOR inhibitor RAD001 (Everloimus) enhances the effects of imatinib in chronic myeloid leukemia by raising the nuclear expression of c-Abl protein 130
P53 oncosuppressor influences selection of genomic imbalances in response to ionizing radiations in human osteosarcoma cell line SAOS-2 123
Genomic instability in the development of non-Hodgkin lymphomas secondary to Hodgkin lymphoma 123
A new class of dual SRC/ABL kinase inhibitors for the treatment of imatinib-resistant chronic myeloid leukemias 123
The m-TOR inhibitor everolimus complements pro-apoptotic and anti-proliferative effects of imatinib on chronic myeloid leukemia progenitors by promoting the nuclear import of normal c-Abl protein 122
COVALENT MODIFICATIONS OF HISTONE H4 NH2-TERMINAL TAILS ASSOCIATED WITH P210 BCR-ABL TYROSINE KINASE 118
DNA methyltransferase 1 drives transcriptional down-modulation of β catenin antagonist Chibby1 associated with the BCR-ABL1 gene of chronic myeloid leukemia. 118
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas. 118
P210 BCR-ABL TYROSINE KINASE INHIBITS APOPTOTIC CELL DEATH THROUGH MULTIPLE PATHWAYS PREVENTING EARLY MITOCHONDRIAL ACTIVATION 116
New SRC/ABL inhibitors for chronic myeloid leukemia therapy show selectivity for T315I ABL mutant CD34(+) cells 116
RAD001 (everolimus) prevents mTOR and Akt late re-activation in response to imatinib in chronic myeloid leukemia 114
Cyclin-dependent kinase 2 (Cdk2) activity at the G1 to S boundary has a role in the resistance of Chronic Myeloid Leukemia (CML) haematopoietic progenitors to the tyrosine kinase inhibitor STI571 (Imatinib) 112
Post-translational modifications of FOXO3a transcription factor associated with the constitutive tyrosine kinase activity of p210 BCR-ABL protein. Implications for new targeted therapies 111
P210 BCR-ABL tyrosine kinase prevents apoptotic cell death through multiple pathways converging at mitochondrial membranes 110
Idetification of the first non-peptidic small molecule inhibitor of the c-Abl/14-3-3 protein-protein interactions able to drive sensitive and Imatinib-resistant leukemia cells to apoptosis. 93
We are very happy and proud of this monographic issue of the Giornale Italiano di Dermatologia e Venereologia. Introduction. 79
La tirosin-cinasi del prodotto p210 di bcr-abl sopprime l'apoptosi mitocondrio dipendente 72
The Haemolymphopathology Italian Group (H.I.G.): an essential resource for the new technical and organization problems troubling modern haemolymphopathology diagnostics 67
NEW STRATEGIES IN THE TREATMENT OF CHRONIC MYELOID LEUKEMIA. COMBINED USE OF SRC AND TYROSINE KINASE INHIBITORS CIRCUMVENTS THE DEVELOPMENT OF DRUG-RESISTANCE 65
Computational techniques are valuable tools for the discovery of protein-protein interaction inhibitors: the 14-3-3 sigma case. 2
Totale 7.866
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.775
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.775
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021580 0 0 0 0 0 50 10 63 74 37 56 290
2021/20221.118 190 28 86 81 87 58 27 58 31 72 210 190
2022/20231.189 133 205 71 145 82 107 25 51 189 32 85 64
2023/2024304 18 49 16 49 19 79 22 14 8 13 8 9
2024/20251.016 19 149 96 73 181 61 53 62 10 139 15 158
2025/20261.307 217 214 193 164 372 147 0 0 0 0 0 0
Totale 7.866